Aurobindo Pharma Q4 net profit falls 28 per cent; revenue dips three per cent
The company had posted a consolidated net profit of Rs 801.18 crores in the same period of the preceding fiscal, Aurobindo Pharma…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
financial results
Venus Remedies registers 9.22 per cent growth in annual sales for FY 21-22
The company’s annual sales grew from Rs 548.12 crores in FY 2020-21 to Rs 598.65 crores this fiscal
Zydus Lifesciences Q4 profit declines 41 per cent to Rs 397 crores
Consolidated total revenue from operations during the quarter under review stood at Rs 3,863.8 crores as against Rs 3,670.3 crores…
Control Print reports total revenue of Rs 254.26 crores in FY22
EBITDA for the year stood at Rs 60.43 crores, up by 21.3 per cent
Lincoln Pharma reports highest revenue, EBITDA and net profit in FY22
The company reported net profit of Rs 69.36 crores for FY22 as against net profit of Rs 62.25 crores in the corresponding period…
AGI Greenpac releases financial results for Q4
In FY2022, the revenue from operations was of Rs 2,319 crores and Profit After Tax (PAT) grew from Rs 88 crores to Rs 193 crores
P&G announces Q3 results
The company has delivered total sales of Rs 262 crores for the quarter ended 31st March, 2022 vs Rs 214 crores, up by 23 per cent…
Eris Lifesciences Q4 22 revenues at Rs 3,059 million, up 10 per cent YoY
Revenue for Q4 FY22 grew by 10 per cent YoY to Rs 3,059 million, and for FY22 grew by 11.2 per cent YoY to Rs 13,470 million
Alembic reports 11 per cent growth in revenue for Q4 FY22 from Rs 1,280 crores in FY21 to Rs 1,416…
Company recommended dividend of Rs 10 per equity share i.e. 500 per cent
JB Chemicals and Pharmaceuticals reports revenue growth of 10 per cent to Rs 601 crores in Q3 FY22
As per IQVIA, JB was the fastest-growing company among the top 30 companies for CY 2021